UPDATE 1-FDA says asthma drug Xolair raises risk of heart, brain problems – Reuters


GlobalPost

UPDATE 1-FDA says asthma drug Xolair raises risk of heart, brain problems
Reuters
Xolair is an injectible drug that was originally approved in 2003 to treat moderate to severe asthma in adults and children aged 12 or over whose condition was not controlled by inhaled steroids. The drug is also approved to treat chronic idiopathic
FDA says asthma drug Xolair raises risk of heart, brain problemsYahoo News
FDA warns of increased risks of asthma drug XolairAAP News (subscription)
FDA: Asthma Drug May Increase Risk of CV, Cerebrovascular EventsMonthly Prescribing Reference

all 19 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.